HER2 in uterine serous carcinoma

Online journal article in Cytology that offers 1.0 continuing education (CME) credit that can be used to fulfill CC Part II requirements.

Quantity:

Want to save more?

Log into see if you qualify for a lower rate.

Members

save $5.00 or more

Intended Audience: Pathologists, Residents, Clinical Scientists, Pathologist Assistants

Upon completion of this activity, you will be able to:

describe the clinical and prognostic features of uterine serous carcinoma and the role of HER2 as a possible biomarker.
apply the Buza et al. proposed...

Intended Audience: Pathologists, Residents, Clinical Scientists, Pathologist Assistants

Upon completion of this activity, you will be able to:

describe the clinical and prognostic features of uterine serous carcinoma and the role of HER2 as a possible biomarker.
apply the Buza et al. proposed HER2 staining system for interpretation of uterine serous carcinomas.
list factors that influence selection of biopsies, currettings, or hysterectomy specimens for HER2 staining and evaluation.

View More View Less